Ugur Emrah Altiparmak
Research Subjects
Ugur Emrah Altiparmak has a total of 125 co-authors. Here are the top co-authors by number of shared publications:
Sunay Duman
9 shared publications- Ayse Ebru Kilavuzoglu
Acibadem Mehmet Ali Aydinlar University School of Medicine, Istanbul, Turkey
7 shared publications - Cemile Banu Cosar
Department of Ophthalmology, Acibadem University School of Medicine, Istanbul, Turkey
6 shared publications - Nilay Akagun
Department of Ophthalmology Acıbadem Hospital Ankara Ankara Turkey
6 shared publications Remzi Kasim
Department of Ophthalmology, Ministry of Health, Ankara Training and Research Hospital Cebeci, AnkaraTurkey
4 shared publications- Nurten Ünlü
Department of Ophthalmology, Ankara Training and Research Hospital, Turkish Ministry of Health, Ankara, Turkey, saglik.gov.tr
3 shared publications
Latest Publications
- Open Access
- 26 August 2026
- Published by Galenos Yayinevi in Turkish Journal of Ophthalmology
- Vol. 56 (4) , 220-221
The Evolution of Myopia Control Spectacle Lenses in Türkiye
The Evolution of Myopia Control Spectacle Lenses in Türkiye - Turkish Journal of Ophthalmology
- 26 August 2026
- Published by Galenos Yayinevi in Turkish Journal of Ophthalmology
- Vol. 56 (4) , 220-221
Open AccessThe Evolution of Myopia Control Spectacle Lenses in Türkiye
The Evolution of Myopia Control Spectacle Lenses in Türkiye - Turkish Journal of Ophthalmology
- Open Access
Real-World Effectiveness of CARE-Based Spectacle Lenses for Myopia Control in a Turkish Pediatric Cohort
Childhood myopia progression remains a major global public health concern, and spectacle lenses designed to induce peripheral myopic defocus have emerged as a non-pharmacological strategy for myopia control; however, real-world evidence from European populations remains limited. This retrospective observational study evaluated the 12-month real-world effectiveness of cylindrical annular refractive element spectacle lenses in a Turkish pediatric cohort. Children aged 5–15 years who wore myopia-control spectacle lenses from the CARE platform or single-vision lenses were included. Cycloplegic spherical equivalent refraction (SER) and axial length (AL) were measured at baseline and at 12 months. The primary outcomes were 12-month changes in SER and AL. Multivariable generalized estimation equations were applied to account for inter-eye correlation and to adjust for age and gender. A total of 168 eyes were analyzed (85 with single-vision lenses; 83 with myopia-control lenses). After 12 months, the myopia-control group demonstrated significantly slower progression than the single-vision group, with mean SER changes of −0.40 ± 0.92 D versus −0.77 ± 0.74 D and axial elongation of 0.17 ± 0.25 mm versus 0.31 ± 0.30 mm, respectively. Treatment group remained a significant predictor of both refractive progression (p = 0.008) and axial elongation (p = 0.003). Age was independently associated with axial length change (p < 0.001), whereas gender was not. These findings provide real-world European evidence supporting the role of defocus-modulating spectacle lenses in pediatric myopia management.
Open AccessReal-World Effectiveness of CARE-Based Spectacle Lenses for Myopia Control in a Turkish Pediatric Cohort
Childhood myopia progression remains a major global public health concern, and spectacle lenses designed to induce peripheral myopic defocus have emerged as a non-pharmacological strategy for myopia control; however, real-world evidence from European populations remains limited. This retrospective observational study evaluated the 12-month real-world effectiveness of cylindrical annular refractive element spectacle lenses in a Turkish pediatric cohort. Children aged 5–15 years who wore myopia-control spectacle lenses from the CARE platform or single-vision lenses were included. Cycloplegic spherical equivalent refraction (SER) and axial length (AL) were measured at baseline and at 12 months. The primary outcomes were 12-month changes in SER and AL. Multivariable generalized estimation equations were applied to account for inter-eye correlation and to adjust for age and gender. A total of 168 eyes were analyzed (85 with single-vision lenses; 83 with myopia-control lenses). After 12 months, the myopia-control group demonstrated significantly slower progression than the single-vision group, with mean SER changes of −0.40 ± 0.92 D versus −0.77 ± 0.74 D and axial elongation of 0.17 ± 0.25 mm versus 0.31 ± 0.30 mm, respectively. Treatment group remained a significant predictor of both refractive progression (p = 0.008) and axial elongation (p = 0.003). Age was independently associated with axial length change (p < 0.001), whereas gender was not. These findings provide real-world European evidence supporting the role of defocus-modulating spectacle lenses in pediatric myopia management.
- Open Access
- 18 February 2026
- Published by Galenos Yayinevi in Turkish Journal of Ophthalmology
- Vol. 56 (1) , 8-15
Real-World Comparison of the Effectiveness of Defocus Incorporated Multiple Segments and Myopi-X Spectacle Lenses for Myopia Control in Turkish Children: A Retrospective Study
Real-World Comparison of the Effectiveness of Defocus Incorporated Multiple Segments and Myopi-X Spectacle Lenses for Myopia Control in Turkish Children: A Retrospective Study - Turkish Journal of Ophthalmology
- 18 February 2026
- Published by Galenos Yayinevi in Turkish Journal of Ophthalmology
- Vol. 56 (1) , 8-15
Open AccessReal-World Comparison of the Effectiveness of Defocus Incorporated Multiple Segments and Myopi-X Spectacle Lenses for Myopia Control in Turkish Children: A Retrospective Study
Real-World Comparison of the Effectiveness of Defocus Incorporated Multiple Segments and Myopi-X Spectacle Lenses for Myopia Control in Turkish Children: A Retrospective Study - Turkish Journal of Ophthalmology
- Open Access
Real-World Effectiveness of DIMS Spectacle Lenses for Myopia Control in a Turkish Pediatric Population: A Retrospective Study Using Age-Specific Physiological Growth Curves
Background/Objectives: This study aimed to evaluate the one-year real-world effectiveness of Defocus Incorporated Multiple Segments (DIMS) spectacle lenses in controlling myopia progression in a Turkish pediatric cohort and to identify predictors of treatment response using age-specific physiological growth curves. Methods: This retrospective single-center study included 54 patients (108 eyes) aged 6–16 years with myopia who wore DIMS spectacle lenses full time for 12 months. The primary outcomes were spherical equivalent refraction (SER) success and axial length (AL)-based treatment response. Treatment success was defined as an SER progression of ≤0.50 dioptres per year and AL elongation within age-specific physiological limits. Subgroup analyses were performed according to age, gender, and the baseline AL group. Results: After 12 months, the mean AL elongation was 0.14 ± 0.31 mm, and the mean SER change was −0.28 ± 0.42 D. SER-based success was achieved in 85.2% of eyes. For AL-based response, 61.1% of eyes showed a good response, 16.7% showed a low–moderate response, and 22.2% had no response. Eyes with moderate baseline AL exhibited significantly less axial elongation than those with high baseline AL (p = 0.001). Children aged ≥ 10 years demonstrated better AL-based responses (p = 0.016). The baseline AL group significantly predicted the AL treatment response, while both the baseline AL group and gender predicted SER success. Gender was associated with SER outcomes but not with AL-based response. Conclusions: DIMS spectacle lenses effectively reduced myopia progression and axial elongation in this real-world Turkish pediatric cohort. Baseline AL and gender were significant predictors of treatment outcomes. Incorporating age-specific physiological growth curves provided an individualized framework for interpreting treatment success. Further prospective studies with larger samples and longer follow-up are warranted to confirm these findings.
Open AccessReal-World Effectiveness of DIMS Spectacle Lenses for Myopia Control in a Turkish Pediatric Population: A Retrospective Study Using Age-Specific Physiological Growth Curves
Background/Objectives: This study aimed to evaluate the one-year real-world effectiveness of Defocus Incorporated Multiple Segments (DIMS) spectacle lenses in controlling myopia progression in a Turkish pediatric cohort and to identify predictors of treatment response using age-specific physiological growth curves. Methods: This retrospective single-center study included 54 patients (108 eyes) aged 6–16 years with myopia who wore DIMS spectacle lenses full time for 12 months. The primary outcomes were spherical equivalent refraction (SER) success and axial length (AL)-based treatment response. Treatment success was defined as an SER progression of ≤0.50 dioptres per year and AL elongation within age-specific physiological limits. Subgroup analyses were performed according to age, gender, and the baseline AL group. Results: After 12 months, the mean AL elongation was 0.14 ± 0.31 mm, and the mean SER change was −0.28 ± 0.42 D. SER-based success was achieved in 85.2% of eyes. For AL-based response, 61.1% of eyes showed a good response, 16.7% showed a low–moderate response, and 22.2% had no response. Eyes with moderate baseline AL exhibited significantly less axial elongation than those with high baseline AL (p = 0.001). Children aged ≥ 10 years demonstrated better AL-based responses (p = 0.016). The baseline AL group significantly predicted the AL treatment response, while both the baseline AL group and gender predicted SER success. Gender was associated with SER outcomes but not with AL-based response. Conclusions: DIMS spectacle lenses effectively reduced myopia progression and axial elongation in this real-world Turkish pediatric cohort. Baseline AL and gender were significant predictors of treatment outcomes. Incorporating age-specific physiological growth curves provided an individualized framework for interpreting treatment success. Further prospective studies with larger samples and longer follow-up are warranted to confirm these findings.
- 20 May 2025
- Published by Springer Nature in Ophthalmic and Physiological Optics
- Vol. 45 (5) , 1090-1097
Defocus incorporated multiple segments spectacle lenses for myopia control: A retrospective study in a Turkish cohort
Purpose: This study evaluated the effectiveness of defocus incorporated multiple segments (DIMS) spectacle lenses in controlling myopia progression and axial elongation in a Turkish paediatric population over a 12‐month period. Methods: This retrospective observational study included 97 children (194 eyes), aged 6–16 years, who were prescribed either DIMS lenses ( n = 54) or single vision spectacle lenses (SVSLs, n = 43). Cycloplegic spherical equivalent refraction (SER) and axial length (AL) were measured at baseline and after 12 months. Treatment effectiveness was assessed using generalised estimating equations (GEE) and subgroup analyses were conducted based on age group, gender and baseline AL. Results: After 12 months, the DIMS group exhibited significantly less myopia progression (−0.28 D [0.42]) compared with the SVSL group (−0.74 D [0.75]), indicating a 62% reduction in SER progression ( p < 0.001). Axial elongation was also significantly lower in the DIMS group (0.14 mm [0.31]) than in the SVSL group (0.29 mm [0.31]), corresponding to a 52% reduction ( p < 0.001). Subgroup analyses revealed that younger age and high baseline AL were consistently associated with greater SER progression and AL elongation across both groups. In the DIMS group, high baseline AL predicted poorer outcomes, but age and gender were not significant predictors. Conclusions: DIMS spectacle lenses effectively reduced myopia progression and axial elongation in children compared with SVSLs. These lenses offer a safe and non‐invasive method for myopia control, being especially beneficial for younger patients or those with higher baseline axial length.
- 20 May 2025
- Published by Springer Nature in Ophthalmic and Physiological Optics
- Vol. 45 (5) , 1090-1097
Defocus incorporated multiple segments spectacle lenses for myopia control: A retrospective study in a Turkish cohort
Purpose: This study evaluated the effectiveness of defocus incorporated multiple segments (DIMS) spectacle lenses in controlling myopia progression and axial elongation in a Turkish paediatric population over a 12‐month period. Methods: This retrospective observational study included 97 children (194 eyes), aged 6–16 years, who were prescribed either DIMS lenses ( n = 54) or single vision spectacle lenses (SVSLs, n = 43). Cycloplegic spherical equivalent refraction (SER) and axial length (AL) were measured at baseline and after 12 months. Treatment effectiveness was assessed using generalised estimating equations (GEE) and subgroup analyses were conducted based on age group, gender and baseline AL. Results: After 12 months, the DIMS group exhibited significantly less myopia progression (−0.28 D [0.42]) compared with the SVSL group (−0.74 D [0.75]), indicating a 62% reduction in SER progression ( p < 0.001). Axial elongation was also significantly lower in the DIMS group (0.14 mm [0.31]) than in the SVSL group (0.29 mm [0.31]), corresponding to a 52% reduction ( p < 0.001). Subgroup analyses revealed that younger age and high baseline AL were consistently associated with greater SER progression and AL elongation across both groups. In the DIMS group, high baseline AL predicted poorer outcomes, but age and gender were not significant predictors. Conclusions: DIMS spectacle lenses effectively reduced myopia progression and axial elongation in children compared with SVSLs. These lenses offer a safe and non‐invasive method for myopia control, being especially beneficial for younger patients or those with higher baseline axial length.
- Open Access
- 25 April 2025
- Published by Galenos Yayinevi in Turkish Journal of Ophthalmology
- Vol. 55 (2) , 61-66
Evaluation of Reasons for Discontinuation of Atropine 0.01% in Myopia Management: A Single-Center Retrospective Study from Türkiye
Evaluation of Reasons for Discontinuation of Atropine 0.01% in Myopia Management: A Single-Center Retrospective Study from Türkiye - Turkish Journal of Ophthalmology
- 25 April 2025
- Published by Galenos Yayinevi in Turkish Journal of Ophthalmology
- Vol. 55 (2) , 61-66
Open AccessEvaluation of Reasons for Discontinuation of Atropine 0.01% in Myopia Management: A Single-Center Retrospective Study from Türkiye
Evaluation of Reasons for Discontinuation of Atropine 0.01% in Myopia Management: A Single-Center Retrospective Study from Türkiye - Turkish Journal of Ophthalmology
- Open Access
- 5 February 2025
- Published by Galenos Yayinevi in Turkish Journal of Ophthalmology
- Vol. 55 (1) , 1-5
Combination Therapy with Atropine 0.05% and Myopi-X® Glasses: Is it Effective in Myopia Control?
To investigate whether the combination therapy of Myopi-X® peripheral progressive addition lenses (PAL; Novax®) and atropine 0.05% provides an additive effect compared to monotherapies with either Myopi-X® PAL or atropine 0.05%. This retrospective cross-sectional study reviewed the clinical records of 51 patients, categorized into three groups: 27 in the Myopi-X group, 13 in the atropine 0.05% group, and 11 in the combination therapy group using Myopi-X peripheral PAL with atropine 0.05%. Baseline characteristics, including age, cycloplegic spherical equivalent (SE), and axial length (AL), were compared between the groups. Twelve months after treatment initiation, changes in SE and AL were assessed and compared between the groups. Among the 51 patients analyzed, the baseline characteristics differed significantly between the groups, with the atropine 0.05% group showing a higher average age, longer AL, and lower SE compared to the other groups. After 12 months, no significant differences were found in SE changes between the treatment groups (p=0.35). Similarly, changes in AL did not significantly differ between the groups (p=0.10), although age had a significant impact on AL change (p=0.01). No significant differences were observed in pairwise comparisons of SE or AL changes between the groups. In this study, combining atropine 0.05% with Myopi-X PALs did not provide an additive benefit. The literature suggests that both treatments are effective in slowing myopia progression individually; however, in our study, their combination did not significantly improve SE progression or axial elongation compared to monotherapies. Further randomized studies with larger patient groups are needed to confirm these findings and assess long-term effects.
- 5 February 2025
- Published by Galenos Yayinevi in Turkish Journal of Ophthalmology
- Vol. 55 (1) , 1-5
Open AccessCombination Therapy with Atropine 0.05% and Myopi-X® Glasses: Is it Effective in Myopia Control?
To investigate whether the combination therapy of Myopi-X® peripheral progressive addition lenses (PAL; Novax®) and atropine 0.05% provides an additive effect compared to monotherapies with either Myopi-X® PAL or atropine 0.05%. This retrospective cross-sectional study reviewed the clinical records of 51 patients, categorized into three groups: 27 in the Myopi-X group, 13 in the atropine 0.05% group, and 11 in the combination therapy group using Myopi-X peripheral PAL with atropine 0.05%. Baseline characteristics, including age, cycloplegic spherical equivalent (SE), and axial length (AL), were compared between the groups. Twelve months after treatment initiation, changes in SE and AL were assessed and compared between the groups. Among the 51 patients analyzed, the baseline characteristics differed significantly between the groups, with the atropine 0.05% group showing a higher average age, longer AL, and lower SE compared to the other groups. After 12 months, no significant differences were found in SE changes between the treatment groups (p=0.35). Similarly, changes in AL did not significantly differ between the groups (p=0.10), although age had a significant impact on AL change (p=0.01). No significant differences were observed in pairwise comparisons of SE or AL changes between the groups. In this study, combining atropine 0.05% with Myopi-X PALs did not provide an additive benefit. The literature suggests that both treatments are effective in slowing myopia progression individually; however, in our study, their combination did not significantly improve SE progression or axial elongation compared to monotherapies. Further randomized studies with larger patient groups are needed to confirm these findings and assess long-term effects.
- Open Access
- 29 December 2018
- Published by Cukurova Medical Journal in Cukurova Medical Journal
- Vol. 43 (4) , 915-922
Arka kapsül bütünlüğü olmayan olgularda arka kamara göz içi mercek implantasyonu
Amaç: Bu çalışmanın amacı yeterli arka kapsüler desteği olmayan hastalarda primer iris-fiksasyonlu ve skleral fiksasyonlu arka kamara göz içi mercek implantasyonlarının sonuçlarını karşılaştırmaktır.Gereç ve Yöntem: Katarakt ameliyatı sırasında yetersiz arka kapsül desteği nedeniyle primer sütüre arka kamara göz içi mercek implantasyonu yapılan hastaların prospektif analizi yapıldı. En iyi düzeltilmiş görme keskinliği, görme keskinliği artışı ve gelişen komplikasyonlar değerlendirildi.Bulgular: Çalışmamızda 13 hastaya (%30,2) iris-fiksasyonlu ve 30 hastaya (% 69,8) skleral fiksasyonlu arka kamara göz içi mercek implantasyonu uygulandı. İris fiksasyonlu grupta 11 hastada (%84,6), skleral fiksasyonlu grupta 25 hastada (%83,3) görme keskinliği , Snellen eşeline göre en az 1 sıra arttı. İris fiksasyonlu grupta % 30,8 hastada (n = 4), skleral fiksasyonlu grupta % 50 hastada (n = 15) 0,5 ve üzerinde en iyi düzeltilmiş görme keskinliği mevcuttu. Sonuç: Primer iris-fiksasyonlu ve skleral fiksasyonlu arka kamara göz içi mercek implantasyonları tatmin edici görsel sonuçlar vermektedir. Sütüre arka kamara göz içi merceğin fikse edileceği bölgenin seçiminde altı çizilmesi gereken noktalar; gözünün ameliyat öncesi durumu, arka kamara göz içi merceğin fikse edilecek bölgenin durumu, lensin türü ve cerrahın tercihidir.
- 29 December 2018
- Published by Cukurova Medical Journal in Cukurova Medical Journal
- Vol. 43 (4) , 915-922
Open AccessArka kapsül bütünlüğü olmayan olgularda arka kamara göz içi mercek implantasyonu
Amaç: Bu çalışmanın amacı yeterli arka kapsüler desteği olmayan hastalarda primer iris-fiksasyonlu ve skleral fiksasyonlu arka kamara göz içi mercek implantasyonlarının sonuçlarını karşılaştırmaktır.Gereç ve Yöntem: Katarakt ameliyatı sırasında yetersiz arka kapsül desteği nedeniyle primer sütüre arka kamara göz içi mercek implantasyonu yapılan hastaların prospektif analizi yapıldı. En iyi düzeltilmiş görme keskinliği, görme keskinliği artışı ve gelişen komplikasyonlar değerlendirildi.Bulgular: Çalışmamızda 13 hastaya (%30,2) iris-fiksasyonlu ve 30 hastaya (% 69,8) skleral fiksasyonlu arka kamara göz içi mercek implantasyonu uygulandı. İris fiksasyonlu grupta 11 hastada (%84,6), skleral fiksasyonlu grupta 25 hastada (%83,3) görme keskinliği , Snellen eşeline göre en az 1 sıra arttı. İris fiksasyonlu grupta % 30,8 hastada (n = 4), skleral fiksasyonlu grupta % 50 hastada (n = 15) 0,5 ve üzerinde en iyi düzeltilmiş görme keskinliği mevcuttu. Sonuç: Primer iris-fiksasyonlu ve skleral fiksasyonlu arka kamara göz içi mercek implantasyonları tatmin edici görsel sonuçlar vermektedir. Sütüre arka kamara göz içi merceğin fikse edileceği bölgenin seçiminde altı çizilmesi gereken noktalar; gözünün ameliyat öncesi durumu, arka kamara göz içi merceğin fikse edilecek bölgenin durumu, lensin türü ve cerrahın tercihidir.
- 11 September 2018
- Published by Taylor & Francis in Cutaneous and Ocular Toxicology
- Vol. 38 (1) , 18-24
Antioxidant effects of vitamin D on lacrimal glands against high dose radioiodine-associated damage in an animal model
Purpose: To evaluate antioxidant effects of active vitamin D (calcitriol) against high-dose radioiodine (RAI) therapy-associated damage of lacrimal gland. Materials and methods: Wistar albino rats were used and divided into three groups randomly (n = 12/group). The first group was appointed as the negative control group and received no RAI or medication. The second group was appointed as the positive control group that only received 3 mCi/kg (111 MBq/kg) RAI via gastric gavage and the last group was the treatment group that received 3 mCi/kg RAI via same method and calcitriol (200 ng/kg/day) via intraperitoneal administration. Seven days after RAI administration, bilateral intraorbital (IG), extraorbital (EG) and Harderian (HG) glands were removed for the evaluations of histopathologic, tissue cytokine, total oxidant status (TOS) and total antioxidant status (TAS). Results: RAI led to significant increase in tissue TOS, TNF-α, IL-6 levels and significant decrease in IL-10 and TAS levels (p < 0.05 for each). Addition of adjunctive calcitriol reversed all these parameters significantly (p < 0.05 for each).The following histopathologic parameters were seen more frequently in positive control group than the other groups: Abnormal lobular pattern, perivascular infiltration, periductal infiltration, lipofuscin-like accumulation, acinar atrophy, periductal and periacinar fibrosis in all lacrimal gland types (p < 0.05), acinar fibrosis in EG (p = 0.049), periductal fibrosis in EG and HG (p = 0.049 and 0.038, respectively), abnormal cell outlines in EG and HG (p = 0.020 and 0.011, respectively) and variation in cell size in the IG and the HG (p = 0.003 and 0.049 respectively). Conclusions: RAI caused significant oxidative stress and inflammation in lacrimal glands. Vitamin D demonstrated potent anti-inflammatory, antioxidant and radio-protective effects on lacrimal glands in histopathologic, tissue cytokine and oxidant/antioxidant level evaluations.
- 11 September 2018
- Published by Taylor & Francis in Cutaneous and Ocular Toxicology
- Vol. 38 (1) , 18-24
Antioxidant effects of vitamin D on lacrimal glands against high dose radioiodine-associated damage in an animal model
Purpose: To evaluate antioxidant effects of active vitamin D (calcitriol) against high-dose radioiodine (RAI) therapy-associated damage of lacrimal gland. Materials and methods: Wistar albino rats were used and divided into three groups randomly (n = 12/group). The first group was appointed as the negative control group and received no RAI or medication. The second group was appointed as the positive control group that only received 3 mCi/kg (111 MBq/kg) RAI via gastric gavage and the last group was the treatment group that received 3 mCi/kg RAI via same method and calcitriol (200 ng/kg/day) via intraperitoneal administration. Seven days after RAI administration, bilateral intraorbital (IG), extraorbital (EG) and Harderian (HG) glands were removed for the evaluations of histopathologic, tissue cytokine, total oxidant status (TOS) and total antioxidant status (TAS). Results: RAI led to significant increase in tissue TOS, TNF-α, IL-6 levels and significant decrease in IL-10 and TAS levels (p < 0.05 for each). Addition of adjunctive calcitriol reversed all these parameters significantly (p < 0.05 for each).The following histopathologic parameters were seen more frequently in positive control group than the other groups: Abnormal lobular pattern, perivascular infiltration, periductal infiltration, lipofuscin-like accumulation, acinar atrophy, periductal and periacinar fibrosis in all lacrimal gland types (p < 0.05), acinar fibrosis in EG (p = 0.049), periductal fibrosis in EG and HG (p = 0.049 and 0.038, respectively), abnormal cell outlines in EG and HG (p = 0.020 and 0.011, respectively) and variation in cell size in the IG and the HG (p = 0.003 and 0.049 respectively). Conclusions: RAI caused significant oxidative stress and inflammation in lacrimal glands. Vitamin D demonstrated potent anti-inflammatory, antioxidant and radio-protective effects on lacrimal glands in histopathologic, tissue cytokine and oxidant/antioxidant level evaluations.
- 3 April 2018
- Published by Taylor & Francis in Journal of Binocular Vision and Ocular Motility
- Vol. 68 (2) , 54-58
The Role of Dynamic Retinoscopy in Predicting Infantile Accommodative Esotropia and Influencing Emmetropization
Introduction and Purpose: To investigate the role that dynamic retinoscopy can play in reducing the occurrence of infantile accommodative esotropia and facilitating emmetropization in infants with high hyperopia. Patients and Methods: 211 orthotropic infants under 1 year of age (3.5 to 12 months) identified as having ≥5 diopters of hyperopia in their more hyperopic eye on a routine eye exam. On enrollment, infants underwent an assessment of accommodation using dynamic retinoscopy as well as a cycloplegic refraction. Infants who showed normal accommodation were followed without spectacles. If dynamic retinoscopy showed subnormal accommodation, partial hyperopic correction that allowed for full binocular accommodative responses at near were prescribed. Main outcome measures were the occurrence of esotropia, changes in refractive error, and visual acuity. Results: Of the 211 infants enrolled, 146 showed normal accommodation and were followed without glasses (Group 1). None of these patients developed strabismus. Sixty-five patients showed subnormal accommodation and received partial hyperopic correction (Group 2). Thirty-four of the 65 (52%) in Group 2 did not develop strabismus (Group 2A) and 31 of the 65 (48%) developed strabismus (Group 2B). All 3 groups showed a reduction of hyperopia of 0.37D ± 0.25/year, 0.50D ± 0.28/year, and 0.60D ± 0.20/year in groups 1, 2A, and 2B, respectively. None of the differences between groups were statistically significant. Conclusions: Normal accommodation on dynamic retinoscopy in orthotropic hyperopic infants is a predictor of continued good alignment and such infants can be followed without spectacles. Partial spectacle correction based on dynamic retinoscopy may have a beneficial effect on reducing the development of strabismus without impeding emmetropization. Early binocular accommodative behavior seems to be predictive of infants at risk of developing strabismus.
- 3 April 2018
- Published by Taylor & Francis in Journal of Binocular Vision and Ocular Motility
- Vol. 68 (2) , 54-58
The Role of Dynamic Retinoscopy in Predicting Infantile Accommodative Esotropia and Influencing Emmetropization
Introduction and Purpose: To investigate the role that dynamic retinoscopy can play in reducing the occurrence of infantile accommodative esotropia and facilitating emmetropization in infants with high hyperopia. Patients and Methods: 211 orthotropic infants under 1 year of age (3.5 to 12 months) identified as having ≥5 diopters of hyperopia in their more hyperopic eye on a routine eye exam. On enrollment, infants underwent an assessment of accommodation using dynamic retinoscopy as well as a cycloplegic refraction. Infants who showed normal accommodation were followed without spectacles. If dynamic retinoscopy showed subnormal accommodation, partial hyperopic correction that allowed for full binocular accommodative responses at near were prescribed. Main outcome measures were the occurrence of esotropia, changes in refractive error, and visual acuity. Results: Of the 211 infants enrolled, 146 showed normal accommodation and were followed without glasses (Group 1). None of these patients developed strabismus. Sixty-five patients showed subnormal accommodation and received partial hyperopic correction (Group 2). Thirty-four of the 65 (52%) in Group 2 did not develop strabismus (Group 2A) and 31 of the 65 (48%) developed strabismus (Group 2B). All 3 groups showed a reduction of hyperopia of 0.37D ± 0.25/year, 0.50D ± 0.28/year, and 0.60D ± 0.20/year in groups 1, 2A, and 2B, respectively. None of the differences between groups were statistically significant. Conclusions: Normal accommodation on dynamic retinoscopy in orthotropic hyperopic infants is a predictor of continued good alignment and such infants can be followed without spectacles. Partial spectacle correction based on dynamic retinoscopy may have a beneficial effect on reducing the development of strabismus without impeding emmetropization. Early binocular accommodative behavior seems to be predictive of infants at risk of developing strabismus.